Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Eric Sorscher
Emory University, Department: Pediatrics
Should you be removed from our database? Contact us at [email protected]. Read more below.
PNP Therapeutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Investigator earns significant consulting fees from a company that manufactures a device that will be evaluated in this research project.
Investigator stands to receive royalties through former institution as part of an exclusive license agreement with privately-held company that develops and commercializes technology used in this study.
Investigator holds equity in a privately-held company that develops and commercializes technology used in this study.
Investigator is a founder and sits on Board of Directors for a privately-held company that develops and commercializes technology used in this study.
Intratumoral generation of F-Ade to ablate low growth fraction HNSCC
In this project, we describe a tumor cell-killing strategy that has proven safe and robust against non- proliferating cancer cells. The approach is directed towards solid tumors refractory to conventional therapy, with supportive data in both animal models and human subjects. Unlike personalized cancer interventions, the strategy is active against tumors from a large number of subcategories irrespective of underlying driver-type mutations.
Filed on July 12, 2017.
Tell us what you know about Eric Sorscher's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Eric Sorscher filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Eric Sorscher | Emory University | Conflict of Interest | PNP Therapeutics, Inc. | $0 - $4,999 |
| Eric Sorscher | Emory University | Conflict of Interest | PNP Therapeutics, Inc. | Value cannot be readily determined |
| Eric Sorscher | Emory University | Conflict of Interest | PNP Therapeutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.